CONTEXT: Cancer diagnosis and treatment, particularly chemotherapy, has well-established adverse effects on individuals. Exercise has been found to confer benefits to patients, although the current evidence base is limited primarily to patients assessed during or after treatment. Although exercise has been a target of intervention efforts, its relationship to quality of life in patients about to begin chemotherapy has not fully been examined. OBJECTIVES: To examine the relationship of pre-treatment exercise rates to patient's quality of life. METHODS: One hundred ninety-two adults diagnosed with Stages I-IV cancer and Eastern Cooperative Oncology Group performance status ≤ 2, provided data on exercise, distress (anxiety and depression), and health-related quality of life prior to their initial chemotherapy infusion. RESULTS: As predicted, higher rates of exercise activity were associated with lower levels of anxiety and depression, and better overall mental and physical quality of life. These relationships were independent of demographic variables (i.e., body mass index and age) also associated with quality of life in the present analyses. CONCLUSION: These findings further highlight the importance of assessing exercise before the start of chemotherapy as part of broader efforts to link patients to appropriate interventions aimed at enhancing quality of life. Findings also raise the possibility that assessing exercise rates could be useful in matching patients to the type of intervention most likely to benefit them. Future research should use prospective longitudinal designs to further explore this association.
CONTEXT: Cancer diagnosis and treatment, particularly chemotherapy, has well-established adverse effects on individuals. Exercise has been found to confer benefits to patients, although the current evidence base is limited primarily to patients assessed during or after treatment. Although exercise has been a target of intervention efforts, its relationship to quality of life in patients about to begin chemotherapy has not fully been examined. OBJECTIVES: To examine the relationship of pre-treatment exercise rates to patient's quality of life. METHODS: One hundred ninety-two adults diagnosed with Stages I-IV cancer and Eastern Cooperative Oncology Group performance status ≤ 2, provided data on exercise, distress (anxiety and depression), and health-related quality of life prior to their initial chemotherapy infusion. RESULTS: As predicted, higher rates of exercise activity were associated with lower levels of anxiety and depression, and better overall mental and physical quality of life. These relationships were independent of demographic variables (i.e., body mass index and age) also associated with quality of life in the present analyses. CONCLUSION: These findings further highlight the importance of assessing exercise before the start of chemotherapy as part of broader efforts to link patients to appropriate interventions aimed at enhancing quality of life. Findings also raise the possibility that assessing exercise rates could be useful in matching patients to the type of intervention most likely to benefit them. Future research should use prospective longitudinal designs to further explore this association.
Authors: R Segal; W Evans; D Johnson; J Smith; S Colletta; J Gayton; S Woodard; G Wells; R Reid Journal: J Clin Oncol Date: 2001-02-01 Impact factor: 44.544
Authors: M J Dodd; S Dibble; C Miaskowski; S Paul; M Cho; L MacPhail; D Greenspan; G Shiba Journal: J Pain Symptom Manage Date: 2001-06 Impact factor: 3.612
Authors: V Mock; M Pickett; M E Ropka; E Muscari Lin; K J Stewart; V A Rhodes; R McDaniel; P M Grimm; S Krumm; R McCorkle Journal: Cancer Pract Date: 2001 May-Jun
Authors: Melinda L Irwin; Diane Crumley; Anne McTiernan; Leslie Bernstein; Richard Baumgartner; Frank D Gilliland; Andrea Kriska; Rachel Ballard-Barbash Journal: Cancer Date: 2003-04-01 Impact factor: 6.860
Authors: Jennifer A Ligibel; Jeffrey Meyerhardt; John P Pierce; Julie Najita; Laura Shockro; Nancy Campbell; Vicky A Newman; Leslie Barbier; Eileen Hacker; Marie Wood; James Marshall; Electra Paskett; Charles Shapiro Journal: Breast Cancer Res Treat Date: 2011-11-24 Impact factor: 4.872
Authors: Heidi Mason; Mary Beth DeRubeis; Nancy Burke; Melissa Shannon; Danielle Karsies; Gregory Wolf; Avi Eisbruch; Francis Worden Journal: World J Clin Oncol Date: 2016-04-10
Authors: Keith M Thraen-Borowski; Amy Trentham-Dietz; Dorothy Farrar Edwards; Kelli F Koltyn; Lisa H Colbert Journal: J Cancer Surviv Date: 2013-04-02 Impact factor: 4.442
Authors: Maribel Tirado-Gómez; Daniel C Hughes; Velda González-Mercado; Rose A Treviño-Whitaker; Karen Basen-Engquist Journal: P R Health Sci J Date: 2016-06 Impact factor: 0.705
Authors: Kavita D Chandwani; Julie L Ryan; Luke J Peppone; Michelle M Janelsins; Lisa K Sprod; Katie Devine; Lara Trevino; Jennifer Gewandter; Gary R Morrow; Karen M Mustian Journal: Evid Based Complement Alternat Med Date: 2012-07-15 Impact factor: 2.629